INS and breast cancer: The CAP score, body weight, insulin and ALT decreased in the participants taking BC as well as in participants in the placebo group (in BC group, CAP score dropped from 295 ± 38 to 247 ± 42 dB/m, p < 0.001; paired t-test; Table 2).